|
De la Fe C., Grau A., Minguez O., Sánchez A., Esquivel R., Corrales J.C. Multi-platform diagnostic strategy and biosecurity as basis of contagious agalactia control programs in endemic areas. Irish Veterinary Journal. December 2025. 78. 10.1186/s13620-025-00288-1
AÑO: 2025; IF: 2.7
|
|
Corrales J.C., Sánchez A., Hernández X., Amores-Iniesta J., Esnal A., de la Fe C. A Set of Multiresistant Isolates of Mycoplasma bovis Subtype ST-1 with a Variable Susceptibility to Quinolones Are Also Circulating in Spain. Pathogens. April 2024. 13. 10.3390/pathogens13040329
AÑO: 2024; IF: 3.3
|
|
Serrano-Rodriguez JM, Fernandez-Varon E, Rodriguez CMC, Andres-Larrea MIS, Rubio-Langre S, de la Fe C, Dova SW, Bhardwaj P, Sidhu PK, Litterio NJ, Lorenzutti AM. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats. Res Vet Sci. 2023 Jun;159:1-10. doi: 10.1016/j.rvsc.2023.03.026. Epub 2023 Apr 3. PubMed PMID: 37060837.
AÑO: 2023; IF: 2.2
|
|
Galecio JS, Escudero E, Corrales JC, Garcia-Romero E, de la Fe C, Hernandis V, Marin P. Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides. World J Microbiol Biotechnol. 2022 Sep 13;38(12):221. doi: 10.1007/s11274-022-03407-0. PubMed PMID: 36097302; PubMed Central PMCID: PMC9468077.
AÑO: 2022; IF: 4.1
|
|
Sanchez A, Contreras A, Sanchez-Corral ML, Martinez-Nista C, Collado S, Saez JL, Minguez O, de la Fe C. Comparison of Commercial Enzyme-linked Immunosorbent Assays for Diagnosis of Contagious Agalactia Caused By Mycoplasma Agalactiae. J Vet Res. 2022 Mar 10;66(1):95-101. doi: 10.2478/jvetres-2022-0010. eCollection 2022 Mar. PubMed PMID: 35582487; PubMed Central PMCID: PMC8959690.
AÑO: 2022; IF: 1.8
|